Kampala, Uganda | THE INDEPENDENT | On Feb.22, in a notice, Emmanuel Katongole, the Chairman and Co-Founder Quality Chemical Industries Limited announced the changes saying the announcement is made pursuant to Rule 36(2) of the Uganda Securities Exchange Listing Rules 2021. “Quality Chemical Industries Limited wishes to notify its shareholders and …
Read More »Cipla records 74% dip in 1H profit amidst transition to new ownership
Kampala, Uganda | THE INDEPENDENT | Cipla Quality Chemicals Limited has reported a substantial 74% dip in profit after tax to Shs 3.56 billion for the six months ending September 30. The dip is attributed to a significant increase in operating expenses and a shift in the product mix. The company’s …
Read More »Cipla issues profit warning amidst product mix changes
Kampala, Uganda | THE INDEPENDENT | Uganda’s drug manufacturer, Cipla Quality Chemicals Ltd, has issued a profit warning for the six months period ended Sept.202, 2023, citing changes in product mix. The Uganda Securities Exchange-listed firm now expects to report lower net earnings than what it reported during the same period …
Read More »Cipla profit after tax reduce by 21% to Shs 18.9bn
But directors have recommended a dividend of Shs2.5 per share payable in September this year which is higher than Shs2 per share paid last year. Kampala, Uganda | JULIUS BUSINGE | Pharmaceutical manufacturing company Cipla Quality Chemical Industries Limited has reported a 21% decline in profit after tax from Shs24bn in …
Read More »Cipla to sell majority stake in the local subsidiary
The stake sale in Cipla Quality Chemical Industries Ltd can fetch $25-30 million Kampala, Uganda | AGENCIES | Cipla Ltd.’s wholly owned subsidiaries have entered into an agreement with investment management company Africa Capitalworks SSA 3 to sell 51.18% stake in a Ugandan subsidiary. The two subsidiaries, Cipla (EU) Ltd …
Read More »Ugandan manufacturers producing 20 percent of essential medicines: Experts
Kampala, Uganda | THE INDEPENDENT | Ugandan manufacturers still produce very low quantities of essential medicines catering for only about 20 percent of the country’s demand. Speaking at a meeting organized by the Uganda Healthcare Federation, Nevin Bradford, the former CEO of Cipla Quality Chemicals Company said currently, there are over …
Read More »Cipla’s profits rises fivefold to Shs 13.9billion
The company manufactures antiretrovirals, artemisinin-based combination therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, malaria and Hepatitis | THE INDEPENDENT | Cipla Qaulity Chemicals Ltd, the East African nation’s drug manufacturer, has said net profits surged nearly five times to Shs 13.9 billion for the six months ending September driven …
Read More »Cipla to pay shareholders dividend worth Shs 7.3billion
The company recorded the first profit since listing on Uganda Securities Exchange in 2018 | THE INDEPENDENT | Cipla Quality Chemical Industries has reported a better performance for the period ended March 31, 2022, posting a net profit of Shs24bn compared to a loss of Shs10bn in 2020. This performance …
Read More »Cipla’s CEO projects good returns for shareholders
The company is in the process of formulating a strategy to enable it achieve short term and long-term goals Kampala, Uganda | THE INDEPENDENT | Shareholders of Cipla Quality Chemical Industries Limited (CQCIL) are waiting to see how their company performs during the reign of the new chief executive officer …
Read More »Cipla recovers 5.6% of Zambian debt worth Shs 42.9bn
The company recorded Shs 2.8billion profit for the half year period Kampala, Uganda | ISAAC KHISA | Uganda’s drug manufacturer, Cipla Quality Chemicals Ltd, recovered Shs 2.5billion from the Zambian government for the drugs supplied in 2018, helping the company to record a profit from the second time since listing …
Read More »